Page 7 - hypertension_newsletter_v2

REFLECTIONS
Hypertension
Hypertension Global Newsletter #1

ADDITIONAL ARTICLES OF INTEREST SELECTED BY THE SCIENTIFIC Hypertension
PLANNING COMMITTEE

The following is a list of additional articles that the Scientific Planning Committee thought were interesting and clinically relevant. We
invite the reader to explore these articles through the links provided.

1. Worldwide trends in prevalence, mortality, and disability-adjusted life years for hypertensive heart disease from
1990 to 2017. Dai H, et al. Hypertension. 2021 Apr;77(4):1223-1233.

2. The USPSTF recommendation on blood pressure screening: Making 2021 the transformative year in controlling
hypertension. Abdalla M, et al. JAMA. 2021 Apr 27;325(16):1618-1619..
3. Hypertension burden and the risk of new-onset atrial fibrillation: A nationwide population-based study. Lee SR, et al.
Hypertension. 2021 Mar 3;77(3):919-928.

4. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin
receptor blockers: A multinational cohort study. Chen RJ, et al. Hypertension. 2021 Sep;78(3):591-603.

5. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines
versus standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomised, double-
blind, active-controlled trial. Chow CK, et al. Lancet. 2021 Sep 18;398(10305):1043-1052.

6. The pharmacological management of malignant hypertension. Gosse P, et al. J Hypertens. 2020 Nov;38(11):2325-2330.

7. New concept of onco-hypertension and future perspectives. Kidoguchi S, et al. Hypertension. 2021 Jan;77(1):16-27.

8. Blood pressure management in stroke. Gorelick PB, et al. Hypertension. 2020 Dec;76(6):1688-1695.
9. Treatment of hypertension reduces cognitive decline in older adults: A systematic review and meta-analysis. Gupta
A, et al. BMJ Open. 2020 Nov 17;10(11):e038971.

10. Trends in worldwide research in hypertension over the period 1999-2018: A bibliometric study. Devos P, Menard J.
Hypertension. 2020 Nov;76(5):1649-1655.

ACRONYMS:
ACEi, angiotensin-converting enzyme inhibitor; AE, adverse events; ARB, angiotensin receptor blocker; BB, beta blocker; BMI, body
mass index; BP, blood pressure; CCB, calcium channel blocker; CHD, coronary heart disease; CKD, chronic kidney disease; CME,
continuing medical education; CV, cardiovascular; eGFR, estimated glomerular filtration rate; HF, heart failure; RCT, randomized
controlled trial; SBP, systolic blood pressure; SPC, single-pill combinations.

Please give us your feedback. It will only take a minute!

TABLE OF CONTENTS Learn more at: www.serviercardiomedicalhub.com